Recognizing the significant and often overlooked behavioral health needs experienced by individuals and families affected by rare diseases, and for other purposes.
H. Res. 1290 is a House resolution that recognizes the behavioral health needs of individuals and families affected by rare diseases. It describes how rare disease patients and caregivers often face long diagnostic delays, uncertainty, misdiagnosis, trauma, anxiety, depression, and caregiver burnout, and it frames these challenges as structural consequences of rare disease care rather than individual failings. The resolution also highlights barriers to behavioral health access, including workforce shortages, geographic limitations, low reimbursement, fragmented care, and limited integration of behavioral health into rare disease treatment models.
The resolution does not create a new program or mandate changes in law; instead, it expresses the sense of the House and encourages federal agencies, payors, clinicians, and health systems to improve support for this population. It calls on HHS, NIH, and CMS to prioritize behavioral health access in rare disease initiatives, supports standardized peer support programs, encourages culturally competent care, urges investment in the behavioral health workforce, and recommends incentives for continuing medical education on rare diseases and their psychosocial effects. It also promotes collaboration among federal agencies, patient advocates, academic institutions, and community partners.
Because this is a resolution rather than a bill, H. Res. 1290 does not directly amend state law or federal statutes. Its practical impact is advisory: it signals congressional support for integrating behavioral health into rare disease care and may influence federal agency priorities, research funding, reimbursement discussions, clinician training efforts, and advocacy around rare disease services. The resolution could also encourage states, health systems, and insurers to expand peer support, integrated behavioral health, and culturally responsive services for rare disease patients and caregivers.
The overall sentiment reflected in the text is strongly supportive and empathetic toward rare disease patients and families. The resolution presents behavioral health needs as significant, underrecognized, and deserving of greater policy attention, and it frames expanded access to care as a matter of equity and comprehensive treatment. No votes or committee debate are provided, so there is no recorded opposition or amendment activity in the available materials.
The main points of contention implied by the resolution are not about the need for support itself, but about implementation barriers: limited clinician supply, reimbursement rates, fragmented care delivery, and the cost and feasibility of expanding integrated behavioral health services. The resolution also points to gaps in standardized peer support and continuing medical education, suggesting that stakeholders may differ on how much responsibility should fall to federal agencies, payors, health systems, or professional training programs. No specific opposing members or formal objections are included in the available record.